Enliven Therapeutics

ELVN • NASDAQ • Stock Fundamentals

Enliven Therapeutics is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Richard A. Fair, with a market cap of $2.5B.

Market Cap$2.5B

Employees50.0

CEORichard A. Fair

CountryUnited States of America

Healthcare

Biotechnology

Most Recent EarningsMay 7, 2026 · 1 month 5 days agoQ1 2026

Next EarningsAug 12, 2026 · in 2 monthsQ2 2026

Financials

Based on Q1 2026 filing

Common questions about Enliven Therapeutics

Enliven Therapeutics (ELVN) has a market capitalization of $2.5B and trades on NASDAQ.

Enliven Therapeutics has approximately 50 employees.